Data / Drug companies / Metoprolol tartrate
Metoprolol tartrate: 46 companies and 210 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Metoprolol tartrate is listed in the FDA National Drug Code Directory by 46 companies, with 210 products in commercial distribution. 205 of the products (97.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet; injection, solution, and the newest product started marketing on September 10, 2026.
The request: Get every company that lists metoprolol tartrate in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 46
- Products
- 210
- Generic (ANDA) products
- 205 (97.6%)
- Application numbers
- 12
- Routes
- Oral, Intravenous
- Brand names
- Metoprolol, Lopressor, Lopressor
- openFDA record search
- api.fda.gov
Companies that list metoprolol tartrate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| A-S Medication Solutions | 27 | tablet, film coated; tablet | Generic drugs (ANDA) | July 26, 2024 |
| Bryant Ranch Prepack | 12 | tablet, film coated; tablet | Generic drugs (ANDA) | July 26, 2024 |
| Advagen Pharma Ltd | 11 | tablet; tablet, film coated | Generic drugs (ANDA) | August 28, 2025 |
| NuCare Pharmaceuticals,Inc. | 11 | tablet, film coated; tablet | Generic drugs (ANDA) | July 26, 2024 |
| Remedyrepack Inc. | 10 | tablet, film coated; tablet | Generic drugs (ANDA) | September 10, 2026 |
| TruPharma, LLC | 10 | tablet; tablet, film coated | Generic drugs (ANDA) | January 17, 2024 |
| Aphena Pharma Solutions - Tennessee, LLC | 9 | tablet, film coated | Generic drugs (ANDA) | September 11, 2007 |
| Cardinal Health 107, LLC | 9 | tablet, film coated; injection, solution | Generic drugs (ANDA) | July 10, 2026 |
| Preferred Pharmaceuticals Inc. | 7 | tablet, film coated; tablet | Generic drugs (ANDA) | June 6, 2025 |
| Aphena Pharma Solutions - Tennessee, LLC | 5 | tablet | Generic drugs (ANDA) | February 9, 2026 |
| Asclemed USA Inc. | 5 | tablet | Generic drugs (ANDA) | July 26, 2024 |
| Mylan Pharmaceuticals Inc. | 5 | tablet, film coated | Generic drugs (ANDA) | March 29, 2016 |
| Northwind Health Company, LLC | 5 | tablet, film coated | Generic drugs (ANDA) | September 16, 2022 |
| PD-Rx Pharmaceuticals, Inc. | 5 | tablet, film coated; tablet | Generic drugs (ANDA) | March 12, 2026 |
| Proficient Rx LP | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | January 17, 2024 |
| Coupler LLC | 4 | tablet | Generic drugs (ANDA) | December 16, 2025 |
| Direct_Rx | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | June 1, 2026 |
| Medical Purchasing Solutions, LLC | 4 | injection, solution; injection | Generic drugs (ANDA) | March 31, 2020 |
| QPharma, Inc. | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | January 17, 2024 |
| Redpharm Drug | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | July 26, 2024 |
| St. Mary's Medical Park Pharmacy | 4 | tablet, film coated; tablet | Generic drugs (ANDA) | April 22, 2026 |
| Validus Pharmaceuticals LLC | 4 | tablet; solution | New drug applications (NDA) | August 11, 2025 |
| American Health Packaging | 3 | tablet, film coated | Generic drugs (ANDA) | July 26, 2010 |
| Asclemed USA, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 11, 2007 |
| Aurobindo Pharma Limited | 3 | tablet, film coated | Generic drugs (ANDA) | September 11, 2007 |
| Exelan Pharmaceuticals Inc. | 3 | tablet | Generic drugs (ANDA) | February 9, 2026 |
| Golden State Medical Supply, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | January 16, 2004 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 11, 2007 |
| Proficient Rx LP | 3 | tablet, film coated | Generic drugs (ANDA) | September 11, 2007 |
| Rising Pharma Holdings, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 11, 2007 |
| Aurobindo Pharma Limited | 2 | tablet, film coated | Generic drugs (ANDA) | December 7, 2023 |
| HF Acquisition Co LLC, DBA HealthFirst | 2 | injection, solution | Generic drugs (ANDA) | December 14, 2019 |
| Hospira, Inc. | 2 | injection, solution | Generic drugs (ANDA) | June 13, 2022 |
| Legacy Pharmaceutical Packaging, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | September 11, 2007 |
| Mylan Institutional Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | September 20, 2004 |
| Safecor Health, LLC | 2 | tablet, film coated | Generic drugs (ANDA) | February 16, 2026 |
| Baxter Healthcare Corporation | 1 | injection | Generic drugs (ANDA) | September 25, 2012 |
| Fosun Pharma USA Inc. | 1 | injection, solution | Generic drugs (ANDA) | March 18, 2019 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | October 28, 2010 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | Generic drugs (ANDA) | December 13, 2024 |
| Gland Pharma Limited | 1 | injection | Generic drugs (ANDA) | October 6, 2014 |
| Hikma Pharmaceuticals USA Inc. | 1 | injection, solution | Generic drugs (ANDA) | May 30, 2007 |
| PD-Rx Pharmaceuticals, Inc. | 1 | tablet, film coated | Generic drugs (ANDA) | February 23, 2004 |
| ProPharma Distribution | 1 | injection, solution | Generic drugs (ANDA) | July 24, 2008 |
| Proficient Rx LP | 1 | tablet, film coated | Generic drugs (ANDA) | December 1, 2018 |
| Sagent Pharmaceuticals | 1 | injection, solution | Generic drugs (ANDA) | May 10, 2010 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 124 | 59% |
| Tablet | 67 | 31.9% |
| Injection, solution | 14 | 6.7% |
| Injection | 4 | 1.9% |
| Solution | 1 | 0.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 205 | 97.6% |
| New drug applications (NDA) | 4 | 1.9% |
| Authorized generics (NDA) | 1 | 0.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| beta-Adrenergic Blocker | 210 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.